{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:25:49Z","timestamp":1789003549919,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.metabol.2015.10.022","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T15:23:45Z","timestamp":1445613825000},"page":"122-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["The protective effect of trimetazidine on myocardial ischemia\/reperfusion injury through activating AMPK and ERK signaling pathway"],"prefix":"10.1016","volume":"65","author":[{"given":"Zhenling","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanlei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kuznicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanhu","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2015.10.022_bb0005","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2015.10.022_bb0010","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1161\/CIRCULATIONAHA.113.004046","article-title":"The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study","volume":"129","author":"Moran","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2015.10.022_bb0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics \u2014 2014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2015.10.022_bb0020","first-page":"5","article-title":"Comments on the ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"66","author":"Coordinadores","year":"2013","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.metabol.2015.10.022_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1472-8206.2003.00154.x","article-title":"Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine","volume":"17","author":"Stanley","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.metabol.2015.10.022_bb0030","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2015.10.022_bb0035","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2015.10.022_bb0040","first-page":"S8","article-title":"Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?","volume":"12","author":"Lopaschuk","year":"2001","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.metabol.2015.10.022_bb0045","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1538-7836.2011.04331.x","article-title":"Activated protein C protects against myocardial ischemic\/reperfusion injury through AMP-activated protein kinase signaling","volume":"9","author":"Wang","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.metabol.2015.10.022_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1172\/JCI19297","article-title":"AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury","volume":"114","author":"Russell","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2015.10.022_bb0055","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1538-7836.2012.04833.x","article-title":"Activated protein C modulates cardiac metabolism and augments autophagy in the ischemic heart","volume":"10","author":"Costa","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.metabol.2015.10.022_bb0060","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1096\/fj.14-258814","article-title":"Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart","volume":"29","author":"Morrison","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2015.10.022_bb0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bcp.2011.04.004","article-title":"PPAR-gamma and AMPK \u2014 advantageous targets for myocardial ischemia\/reperfusion therapy","volume":"82","author":"Morrison","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.metabol.2015.10.022_bb0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/CIRCULATIONAHA.112.000862","article-title":"Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction","volume":"128","author":"Wang","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2015.10.022_bb0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.110.953208","article-title":"Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart","volume":"122","author":"Ma","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2015.10.022_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cmet.2009.06.008","article-title":"A crystallized view of AMPK activation","volume":"10","author":"Young","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2015.10.022_bb0085","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.17420111","article-title":"AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function","volume":"25","author":"Hardie","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2015.10.022_bb0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-5793(03)00560-X","article-title":"Management of cellular energy by the AMP-activated protein kinase system","volume":"546","author":"Hardie","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.metabol.2015.10.022_bb0095","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S1097-2765(01)00251-9","article-title":"A role of AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle","volume":"7","author":"Mu","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2015.10.022_bb0100","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nature06504","article-title":"Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart","volume":"451","author":"Miller","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2015.10.022_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0047-6374(00)00147-0","article-title":"On the nature of aging","volume":"117","author":"Semsei","year":"2000","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.metabol.2015.10.022_bb0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1517\/13543784.11.5.615","article-title":"Partial fatty acid oxidation inhibitors for stable angina","volume":"11","author":"Stanley","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.metabol.2015.10.022_bb0115","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.bjp.0701755","article-title":"Evidence for the existence of [3H]-trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore","volume":"123","author":"Morin","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2015.10.022_bb0120","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.bjp.0703348","article-title":"[(3)H]-trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance","volume":"130","author":"Morin","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2015.10.022_bb0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0163-7827(95)00011-9","article-title":"beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress","volume":"34","author":"Kunau","year":"1995","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.metabol.2015.10.022_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jgr.2013.11.014","article-title":"AMP-activated protein kinase: an emerging target for ginseng","volume":"38","author":"Jeong","year":"2014","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.metabol.2015.10.022_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0005-2760(96)00013-6","article-title":"Characterization of 5\u2032AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia","volume":"1301","author":"Kudo","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2015.10.022_bb0140","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1126\/science.1056843","article-title":"Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2","volume":"291","author":"Abu-Elheiga","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.metabol.2015.10.022_bb0145","first-page":"802","article-title":"Adiponectin (15-36) stimulates steroidogenic acute regulatory (StAR) protein expression and cortisol production in human adrenocortical cells: role of AMPK and MAPK kinase pathways","volume":"2011","author":"Ramanjaneya","year":"1813","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2015.10.022_bb0150","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0960-9822(00)00742-9","article-title":"Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia","volume":"10","author":"Marsin","year":"2000","journal-title":"Curr Biol"},{"key":"10.1016\/j.metabol.2015.10.022_bb0155","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s10495-006-9037-8","article-title":"Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways","volume":"11","author":"Sun","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.metabol.2015.10.022_bb0160","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.metabol.2015.10.022_bb0165","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1242\/jcs.02470","article-title":"MAP kinase pathways","volume":"118","author":"Qi","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.metabol.2015.10.022_bb0170","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2015.10.022_bb0175","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0022-3565(24)38785-3","article-title":"Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection","volume":"296","author":"Fryer","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.metabol.2015.10.022_bb0180","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.RES.86.6.692","article-title":"Inhibition of extracellular signal-regulated kinase enhances Ischemia\/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart","volume":"86","author":"Yue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2015.10.022_bb0185","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.bjp.0705873","article-title":"Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats","volume":"142","author":"Ferrandi","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2015.10.022_bb0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0039-6060(98)70133-3","article-title":"Hydrogen peroxide induces tumor necrosis factor alpha-mediated cardiac injury by a P38 mitogen-activated protein kinase-dependent mechanism","volume":"124","author":"Meldrum","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.metabol.2015.10.022_bb0195","first-page":"R577","article-title":"Tumor necrosis factor in the heart","volume":"274","author":"Meldrum","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2015.10.022_bb0200","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ejcb.2005.03.002","article-title":"H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44\/42 MAP kinase pathway","volume":"84","author":"Fischer","year":"2005","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.metabol.2015.10.022_bb0205","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.febslet.2006.04.041","article-title":"HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis \u2014 involvement of ERK pathway","volume":"580","author":"Wang","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.metabol.2015.10.022_bb0210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/jpet.109.165175","article-title":"Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling","volume":"333","author":"Khan","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.metabol.2015.10.022_bb0215","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1053\/euhj.2001.2896","article-title":"Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). Trimetazidine in Poland","volume":"22","author":"Szwed","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2015.10.022_bb0220","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/hrt.78.4.353","article-title":"Combination treatment with trimetazidine and diltiazem in stable angina pectoris","volume":"78","author":"Manchanda","year":"1997","journal-title":"Heart"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:09:28Z","timestamp":1758427768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049515003145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0026049515003145"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.10.022","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protective effect of trimetazidine on myocardial ischemia\/reperfusion injury through activating AMPK and ERK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}